IL-6 antagonists may have a role in fighting COVID-19 after all – The Cancer Letter

publication date: Sep. 25, 2020By Paul GoldbergThis story is part of The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. A full list of our coverage is available here.Earlier this year, as doctors observed that patients afflicted with the novel coronavirus were dying from a cytokine release syndrome, some suggested focusing on suppressing production of interleukin-6 to control…

Read the full article here

Related Articles